TALPHERA, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TALPHERA, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $13.00K.
- TALPHERA, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $2.00K.
- TALPHERA, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $2.00K.
- TALPHERA, INC. stock issued during period, value, stock options exercised for the quarter ending 2019-09-30 was $83.00K, a 186.21% increase year-over-year.
- TALPHERA, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $270.00K, a 32.67% decline from fiscal 2018.
- TALPHERA, INC. stock issued during period, value, stock options exercised for fiscal 2018 was $401.00K, a 281.90% increase from fiscal 2017.
- TALPHERA, INC. stock issued during period, value, stock options exercised for fiscal 2017 was $105.00K.
- TALPHERA, INC. stock issued during period, value, stock options exercised for fiscal 2015 was $2.77M.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $17.00K 8-K · filed 2023-08-01 | |
| 2021-09-30 | $13.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $2.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $2.00K 10-Q · filed 2022-11-14 | |
| 2019-12-31 | $270.00K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $83.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $155.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $31.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $401.00K 10-K · filed 2021-03-15 | |
| 2018-09-30 | $29.00K 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $105.00K 10-K · filed 2020-03-16 | |
| 2015-12-31 | $2.77M 10-K · filed 2018-03-09 | |
| 2010-12-31 | $21.00K 10-K · filed 2013-03-12 | |
| 2009-12-31 | $26.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |